Published in Br J Cancer on December 12, 2005
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child (2007) 1.01
Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA. Support Care Cancer (2007) 0.90
A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings. Br J Cancer (2010) 0.80
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis (2002) 7.81
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med (2005) 5.54
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med (1999) 3.02
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol (1992) 1.86
Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis (1997) 1.84
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study. Br J Cancer (2003) 1.62
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev (2004) 1.59
Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer (2004) 1.38
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol (1998) 1.16
Controversies in the management of febrile neutropenic cancer patients. Cancer Invest (1988) 1.10
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer (1994) 1.10
Immunohistochemical detection of p53 protein overexpression in primary human osteosarcomas. Anticancer Res (1997) 0.82
Hantavirus outbreak yields to PCR. Science (1993) 9.80
Dispute slows paper on "remarkable" vaccine. Science (1995) 5.83
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
Gene therapy death prompts review of adenovirus vector. Science (1999) 4.33
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol (1994) 4.08
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med (1996) 3.94
When does intellectual passion become conflict of interest? Science (1992) 3.30
Whose genome is it, anyway? Science (1996) 3.29
Clinical trials. Planned Ritalin trial for tots heads into uncharted waters. Science (2000) 2.70
New Zealand's leap into gene therapy. Science (1996) 2.67
Lyme disease. NIH gears up to test a hotly disputed theory. Science (1995) 2.65
Pneumococcal immunisation and the healthy elderly. Lancet (1992) 2.58
Allen Roses: from 'street fighter' to corporate insider. Science (1998) 2.37
Bermuda rules: community spirit, with teeth. Science (2001) 2.36
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity (1997) 2.18
Drug firms to create public database of genetic mutations. Science (1999) 2.14
Despite anxiety, NIH begins merging neuroscience panels. Science (1996) 2.04
Startling revelations in UC-Genentech battle. Science (1999) 2.04
Alternative medicine. Bastions of tradition adapt to alternative medicine. Science (2000) 2.04
Supreme Court to weigh science. Science (1993) 2.03
NIH panel urges overhaul of the rating system for grants. Science (1996) 2.01
Policy on DNA research troubles tissue bankers. Science (1996) 2.00
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
Epidemiology. Search for a killer: focus shifts from fat to hormones. Science (1993) 1.77
Scientific misconduct. How prevalent is fraud? That's a million-dollar question. Science (2000) 1.73
Neurotoxicity among pesticide applicators exposed to organophosphates. Occup Environ Med (1995) 1.71
Too radical for NIH? Try DARPA. Science (1997) 1.68
Incidence of mycobacterial infections in cats in Great Britain: estimate from feline tissue samples submitted to diagnostic laboratories. Transbound Emerg Dis (2012) 1.68
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study. Br J Cancer (2003) 1.62
Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord (1990) 1.59
Snipping away at genome patenting. Science (1997) 1.57
Varmus proposes to scrap the RAC. Science (1996) 1.57
Data sharing: a declining ethic? Science (1990) 1.56
The mouse that prompted a roar. Science (1997) 1.55
A high-stakes gamble on genome sequencing. Science (1999) 1.51
Congenital defects and electric bed heating in New York State: a register-based case-control study. Am J Epidemiol (1992) 1.46
Toxicology goes molecular. Science (1993) 1.46
Less hype, more biology needed for gene therapy. Science (1995) 1.45
A is for apple, Alar, and ... alarmist? Science (1991) 1.44
The human gene hunt scales up. Science (1996) 1.43
Fallout from Pacific tests reaches Congress. Science (1989) 1.42
Retrospective study of acute toxicity following short-course preoperative radiotherapy. Br J Surg (2002) 1.42
Varmus orders up a review of the science of gene therapy. Science (1995) 1.42
Six-month success of intracoronary stenting for anomalous coronary arteries associated with myocardial ischemia. Am J Cardiol (2000) 1.42
The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med (1993) 1.41
A clash over standards for scientific records. Science (1990) 1.40
A bitter battle over insulin gene. Science (1997) 1.40
Medicine. Fast technology drives new world of newborn screening. Science (2001) 1.40
Is data-hoarding slowing the assault on pathogens? Science (1997) 1.40
Academy panel raises radiation risk estimate. Science (1990) 1.40
Trial set to focus on peer review. Science (1996) 1.40
Anxiety hits mental health institute. Science (1994) 1.39
NIMH: caught in the line of fire without a general. Science (1995) 1.39
Financial conflict. Universities puncture modest regulatory trial balloon. Science (2001) 1.39
NIH told to reconsider crime meeting. Science (1993) 1.39
Paleoanthropology gets physical. Science (1990) 1.39
Rules on embryo research due out. Science (1994) 1.39
Artificial heart: the beat goes on. Science (1991) 1.38
Panel urges cloning ethics board. Science (1997) 1.38
Management overhaul at Johns Hopkins. Science (1995) 1.38
Human Genome Project. Sequencers endorse plan for a draft in 1 year. Science (1999) 1.36
Gene therapy on trial. Science (2000) 1.34
NIH launches the final push to sequence the genome. Science (1996) 1.27
Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol (1997) 1.24
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci (1991) 1.24
Varmus circulates proposal for NIH-backed online venture. Science (1999) 1.22
Human genome. Rival genome sequencers celebrate a milestone together. Science (2000) 1.20
Tobacco science wars. Science (1987) 1.20
Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Mol Pathol (2000) 1.19
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. Ann Oncol (2005) 1.17
Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report. J Clin Oncol (1994) 1.16
Hubris and the human genome. Science (1998) 1.16
Bioethics. Cloning announcement sparks debate and scientific skepticism. Science (2001) 1.13
NIH's online publishing venture ready for launch. Science (1999) 1.12
DNA sequencing. Genome teams adjust to shotgun marriage. Science (2001) 1.12
Tobacco industry does slow burn over EPA adviser. Science (1990) 1.11
A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J Virol Methods (2001) 1.10
Gene therapy's growing pains. Science (1995) 1.09
Medline searches turn up cases of suspected plagiarism. Science (1998) 1.07
Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells. Gene Ther (2008) 1.07
Genome sequencing. Celera assembles mouse genome; public labs plan new strategy. Science (2001) 1.05
Fraud strikes top genome lab. Science (1996) 1.05
T cell selection during the evolution of CD8+ T cell memory in vivo. Eur J Immunol (1998) 1.05
Malaria. A renewed assault on an old and deadly foe. Science (2000) 1.03
The genome project's conscience. Science (1996) 1.02
E-biomed morphs to E-biosci, focus shifts to reviewed papers. Science (1999) 1.00
Hand preference in a normal population. Cortex (1988) 0.99
NIH to produce a 'working draft' of the genome by 2001. Science (1998) 0.99
'Playing chicken' over gene markers. Science (1997) 0.99
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer. Br J Cancer (2005) 0.98
New NIH rules promote greater sharing of tools and materials. Science (1999) 0.98
Senate Turns Up the Heat on NSF. Science (1993) 0.98
Lobbyists seek to reslice NIH's pie. Science (1997) 0.98
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem (1990) 0.97
Identification of factors that disrupt negative air pressurization of respiratory isolation rooms. Infect Control Hosp Epidemiol (2000) 0.96
Nuclear Winter Debate Heats Up: A study by the National Center for Atmospheric Research suggests most of the world would experience a mild nuclear winter, not a deep freeze. Science (1987) 0.96
Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide. Cancer Chemother Pharmacol (1995) 0.95
Shutdown of research at Duke sends a message. Science (1999) 0.95
Drugs. Reinventing an ancient cure for malaria. Science (2000) 0.94